The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model.

Sauvage D, Bosseler M, Viry E, Kanli G, Oudin A, Berchem G, Keunen O, Janji B

Open source

DOI
10.3390/cells11182783
Published
2022 Sep 6
Container
Cells
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cells11182783,
  title = {The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model.},
  author = {Sauvage D and Bosseler M and Viry E and Kanli G and Oudin A and Berchem G and Keunen O and Janji B},
  year = {2022},
  journal = {Cells},
  doi = {10.3390/cells11182783},
  url = {https://doi.org/10.3390/cells11182783}
}

RIS

TY  - JOUR
TI  - The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model.
AU  - Sauvage D
AU  - Bosseler M
AU  - Viry E
AU  - Kanli G
AU  - Oudin A
AU  - Berchem G
AU  - Keunen O
AU  - Janji B
PY  - 2022
JO  - Cells
DO  - 10.3390/cells11182783
UR  - https://doi.org/10.3390/cells11182783
ER  - 

APA

D, S., M, B., E, V., G, K., A, O., G, B., O, K., & B, J. (2022). The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model.. Cells. https://doi.org/10.3390/cells11182783

Source records